The relevancy of the matrix metalloproteinase system to the pathophysiology of endometriosis

review OA: bronze CC0 ⤵ 47 in-corpus citations
AI-generated summary by claude@2026-06, 2026-06-06

This review discusses how altered expression of the matrix metalloproteinase system in endometriosis promotes tissue invasion and remodeling, suggesting therapeutic potential.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-06

This paper is a review of the matrix metalloproteinase (MMP) system, focusing on how the balance between MMPs and their inhibitors (TIMPs) contributes to normal endometrial development and to disease states. It summarizes evidence that both ectopic endometriotic tissue and the eutopic endometrium in women with endometriosis show altered MMP/TIMP expression patterns that support invasion and tissue remodeling. The authors propose that modulating the MMP system could be relevant to limiting or preventing the invasive events underlying endometriosis development and progression, while framing the work as a synthesis of existing knowledge rather than new experimental data. This paper is centrally about endometriosis — it reviews the MMP/TIMP system’s role in endometriosis pathophysiology and potential therapeutic relevance.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

The matrix metalloproteinase (MMP) system is composed of the enzymatic component, the MMPs, and the enzyme inhibitory component, the tissue inhibitors of metalloproteinases or TIMPs. It is well established that the MMP system plays a critical role during the normal development and growth of the endometrium as well as many other physiological processes. Because of the necessity for the balance between MMP and TIMP, it is not surprising that aberrant expression of MMPs and TIMPs is associated with the pathophysiology of many diseases. Included in this list is the female disease endometriosis, a disease in which endometrial tissue grows outside of the uterus usually within the pelvic cavity. Both endometriotic (ectopic) endometrial tissue as well as the eutopic endometrium from women with the disease exhibit altered patterns of MMP and TIMP expression which favor tissue invasion/remodeling by the endometriotic tissue. As such, it has been proposed that successful modulation of the MMP system to limit or prevent the invasive events necessary for endometriosis development and/or progression may open new avenues to the medical management of endometriosis. This review will present general knowledge of the MMP system relative to the pathophysiology of the endometriosis as well as address its potential value in relation to the treatment of the disease.

My notes (saved in your browser only)

Condition tags

mesh:D004715endometriosis

MeSH descriptors

Endometriosis Endometriosis Endometriosis Matrix Metalloproteinases Endometriosis Female Gene Expression Regulation, Enzymologic Humans Matrix Metalloproteinases Tissue Inhibitor of Metalloproteinases Tissue Inhibitor of Metalloproteinases Tumor Necrosis Factor-alpha Tumor Necrosis Factor-alpha

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (47)

Cited by (47)

Source provenance

europepmc
last seen: 2026-06-04T01:30:01.192114+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:12:26.305326+00:00
License: CC0 · commercial use OK